(Q62055104)

English

Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

MMFSSC (English)

0 references

title

Mycophenolate Mofetil in Systemic Sclerosis: A Phase 1 Pharmacokinetic Study of Orally Ingested Mycophenolate Mofetil Tablets in Patients Suffering From Systemic Sclerosis (English)

0 references

0 references

0 references

0 references

13 September 2018

0 references

end time

1 January 2020

0 references

number of participants

35

0 references

research intervention

mycophenolic acid

0 references

research subject recruitment status

completed

0 references

minimum age

18 year

0 references

study type

observational study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03678987

0 references

(Q62055104)

Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)